AE |
autoimmune encephalitis |
AK5 |
adenylate kinase 5 |
AMPAR |
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
BBB |
blood-brain barrier |
BG |
basal ganglia |
CASPR2 |
contactin-associated protein-like 2 |
CJD |
Creutzfeldt-Jakob disease |
CNS |
central nervous system |
CRMP5 |
collapsin response-mediator protein-5 |
CSF |
cerebrospinal fluid |
DPPX/DPP6 |
dipeptidyl peptidase-like protein 6 |
EEG |
electroencephalography |
FDG-PET |
fluorodeoxyglucose-positron emission tomography |
FLAIR |
fluid-attenuated inversion recovery |
GABA-BR |
γ-aminobutyric acid B receptor |
GAD |
glutamic acid decarboxylase |
GlyR |
glycine receptor |
HIV |
human immunodeficiency virus |
HSV |
herpes simplex virus |
HHV6 |
human herpesvirus 6 |
ICI |
immune checkpoint inhibitor |
IL |
interleukin |
INF-γ |
interferon-γ |
LE |
limbic encephalitis |
LGI1 |
leucine-rich, glioma inactivated 1 |
mGluR5 |
metabotropic glutamate receptor subtype 5 |
MRI |
magnetic resonance imaging |
NK |
natural killer |
NMDAR |
N-methyl-D-aspartate receptor |
OCB |
oligoclonal band |
PNS |
paraneoplastic syndrome |
SLE |
systemic lupus erythematosus |
SOX1 |
sex-determining region Y (SRY)-box 1 |
SPS |
stiff-person syndrome |
VZV |
varicella zoster virus |